Table 1.
Patient characteristics
|
|
Hilar group (n = 83)
|
Lower group (n = 44)
|
P
value
|
| Age, yr | 68.4 ± 11.8 | 71.2 ± 11.2 | 0.22 |
| Sex | |||
| Female | 33 (39.8) | 16 (36.4) | 0.85 |
| Male | 50 (60.2) | 28 (63.6) | |
| ALT, U/L | 126.0 ± 116.3 | 174.8 ± 177.1 | 0.11 |
| TB, mg/dL | 5.9 ± 7.5 | 6.8 ± 6.8 | 0.47 |
| Cause of stricture | 0.77 | ||
| Pancreaticobiliary tumor | 73 (88.0) | 40 (90.9) | |
| Pancreas | 67 | 31 | |
| Biliary tract | 6 | 9 | |
| Metastasis | 10 (12.0) | 4 (9.1) | |
| Lung | 3 | 1 | |
| Stomach | 3 | ||
| Rhabdomyosarcoma | 1 | ||
| Uterine | 1 | ||
| Ovarian | 1 | ||
| Esophagus | 1 | ||
| Breast | 1 | ||
| Colon | 1 | ||
| Lymph node metastasis from gallbladder cancer | 1 | ||
| Chemotherapy | 35 (42.2) | 23 (52.3) | 0.35 |
| Duodenal stricture | 15 (18.1) | 7 (15.9) | 0.81 |
| CBD diameter above stricture, mm | 11.5 ± 4.3 | 12.2 ± 4.0 | 0.40 |
| CBD stricture diameter, mm | 0.61 ± 0.89 | 0.72 ± 0.8 | 0.50 |
| CBD stricture length, cm | 2.64 ± 1.35 | 2.34 ± 1.11 | 0.21 |
Values are presented as the mean ± SD or n (%).
ALT: Alanine transaminase; TB: Total bilirubin; CBD: Common bile duct.